TC
NVO

Truvestments Capital’s Novo Nordisk NVO Stock Holding History

Truvestments Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.2K Sell
1,527
-1,090
-42% -$46.8K 0.01% 465
2026
Q1 		$96.2K Buy
2,617
+978
+60% +$46.3K 0.02% 387
2025
Q4 		$83.4K Sell
1,639
-200
-11% -$10.2K 0.02% 369
2025
Q3 		$102K Sell
1,839
-58
-3% -$3.4K 0.02% 338
2025
Q2 		$131K Sell
1,897
-30
-2% -$2.04K 0.03% 267
2025
Q1 		$134K Sell
1,927
-169
-8% -$14K 0.03% 268
2024
Q4 		$180K Buy
2,096
+113
+6% +$12.2K 0.05% 226
2024
Q3 		$236K Buy
1,983
+29
+1% +$3.87K 0.06% 200
2024
Q2 		$279K Hold
1,954
– – 0.11% 170
2024
Q1 		$251K Hold
1,954
– – 0.1% 182
2023
Q4 		$202K Hold
1,954
– – 0.09% 208
2023
Q3 		$178K Buy
1,954
+60
+3% +$5.29K 0.09% 190
2023
Q2 		$153K Buy
1,894
+2
+0.1% +$163 0.08% 213
2023
Q1 		$150K Buy
1,892
+90
+5% +$6.38K 0.08% 204
2022
Q4 		$122K Hold
1,802
– – 0.07% 211
2022
Q3 		$90K Buy
1,802
+2
+0.1% +$107 0.06% 206
2022
Q2 		$100K Buy
+1,800
New +$99.9K 0.06% 205
2022
Q1 		– Sell
-1,798
Closed -$101K – 415
2021
Q4 		$101K Hold
1,798
– – 0.05% 209
2021
Q3 		$86K Buy
1,798
+2
+0.1% +$97 0.05% 215
2021
Q2 		$75K Buy
1,796
+4
+0.2% +$155 0.04% 220
2021
Q1 		$60K Sell
1,792
-128
-7% -$4.56K 0.03% 264
2020
Q4 		$67K Buy
+1,920
New +$66.4K 0.05% 223
2020
Q3 		– Sell
-1,918
Closed -$62K – 469
2020
Q2 		$62K Sell
1,918
-4,596
-71% -$147K 0.06% 187
2020
Q1 		$196K Buy
+6,514
New +$194K 0.25% 90
2019
Q4 		– Sell
-5,264
Closed -$136K – 434
2019
Q3 		$136K Hold
5,264
– – 0.09% 158
2019
Q2 		$134K Buy
5,264
+4,756
+936% +$118K 0.09% 161
2019
Q1 		$13K Buy
+508
New +$12.5K 0.01% 479
2018
Q3 		$12K Buy
+508
New +$12.4K 0.01% 604

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Truvestments Capital's NVO Position: Q2 2026 in Review

Truvestments Capital reduced its Novo Nordisk (NVO) stake by 42% in Q2 2026, selling an estimated $46.8K and leaving 1,527 shares worth $73.2K. The position accounts for 0.01% of the portfolio, ranked #465.

Truvestments Capital first reported a position in NVO in Q3 2018 and has held it in 28 quarters since. The position peaked at $279K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Truvestments Capital held 1,527 shares of Novo Nordisk worth $73.2K as of Q2 2026.
  • Truvestments Capital sold 1,090 Novo Nordisk shares in Q2 2026, an estimated $46.8K.
  • Novo Nordisk made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #465 holding.
  • Truvestments Capital first reported a position in Novo Nordisk in Q3 2018 and has held it in 28 quarters since.
  • Truvestments Capital's Novo Nordisk position peaked at $279K in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.